Your browser doesn't support javascript.
An Experience of Multiple Hematomas in a Coronavirus Disease-19 Patient Administered with ART-123 and Heparin.
Shiraki, Hideto; Morishita, Koji; Kishino, Mitsuhiro; Nakatsutsumi, Keita; Kimura, Koichiro; Shirai, Tsuyoshi; Ishizuka, Masahiro; Miyazaki, Yasunari; Aiboshi, Junichi; Otomo, Yasuhiro.
  • Shiraki H; Department of Acute Critical Care and Disaster Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Morishita K; Department of Acute Critical Care and Disaster Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Kishino M; Department of Diagnostic Radiology, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Nakatsutsumi K; Department of Acute Critical Care and Disaster Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Kimura K; Department of Diagnostic Radiology, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Shirai T; Department of Respiratory Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Ishizuka M; Department of Respiratory Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Miyazaki Y; Department of Respiratory Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Aiboshi J; Department of Acute Critical Care and Disaster Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
  • Otomo Y; Department of Acute Critical Care and Disaster Medicine, Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan.
Open Access Emerg Med ; 13: 207-211, 2021.
Article in English | MEDLINE | ID: covidwho-1256176
ABSTRACT

BACKGROUND:

Anticoagulant therapy for patients with severe coronavirus disease (COVID-19) pneumonia is considered to improve the hypercoagulable and inflammatory state. However, bleeding complications should also be considered. CASE PRESENTATION A 77-year-old man with a history of falls was diagnosed with COVID-19. Owing to his severe condition, he was intubated and transferred to our hospital for intensive care. Favipiravir, tocilizumab, unfractionated heparin, and ART-123 were administered to treat COVID-19 and manage the antithrombotic prophylaxis for paroxysmal atrial fibrillation (Af). On the 6th day after admission, a hematoma was noted on the left chest wall. Computed tomography (CT) revealed multiple hematomas, including hematomas on his chest wall and obturatorius internus muscle. Emergency angiography transcatheter embolization (TAE) was performed. The patient was transferred to another hospital 23 days after TAE, without complications.

CONCLUSION:

Our findings show that anticoagulation therapy and a history of falls induced multiple hematomas in a COVID-19 patient and that the condition was managed with TAE. When anticoagulants are considered in the management of Af and COVID-19 associated coagulopathy, it is necessary to closely monitor potential bleeding complications.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Open Access Emerg Med Year: 2021 Document Type: Article Affiliation country: Oaem.S302732

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Open Access Emerg Med Year: 2021 Document Type: Article Affiliation country: Oaem.S302732